Autopsy report · NCT00149318

Enzyme Replacement Therapy in Fabry Disease

“Difficulties in the patient's enrolment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 9 months after it had already started.
• Ran for about 11 years 11 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Mario Negri Institute for Pharmacological Research

Sponsor type

University, hospital or other

Conditions

Fabry Disease

Interventions

Biochemical analyses.

Participants

2

Sites

1

Countries

Italy

Trials that died the same way

• Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
  “Insufficient patient enrolment” (86% match in meaning)
• Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
  “difficulty in the enrolment” (77% match in meaning)
• Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI)
  “Difficulty in enrolment” (75% match in meaning)
• The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.
  “no patient enroled” (73% match in meaning)
• Adjunctive Vitamin D in the Treatment of Non-remitted Depression
  “Difficulties with subject enrolment.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.